10:53 AM EST - Oncolytics Biotech Inc. : Announced its financial results for the year ended December 31, 2017. At December 31, 2017, the Company reported $11.8 million in cash, cash equivalents and short-term investments. Net loss, however, amounted to $15.6 million, compared to a loss of $15.1 million in the prior-year. Oncolytics Biotech Inc.
shares T.ONC are trading up $0.01 at $0.79.
